These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 11490027)

  • 1. Fas/Fas ligand deficiency results in altered localization of anti-double-stranded DNA B cells and dendritic cells.
    Fields ML; Sokol CL; Eaton-Bassiri A; Seo S; Madaio MP; Erikson J
    J Immunol; 2001 Aug; 167(4):2370-8. PubMed ID: 11490027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fas and Fas ligand mutations inhibit autoantibody production in pristane-induced lupus.
    Satoh M; Weintraub JP; Yoshida H; Shaheen VM; Richards HB; Shaw M; Reeves WH
    J Immunol; 2000 Jul; 165(2):1036-43. PubMed ID: 10878381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MRL-lpr/lpr mice exhibit a defect in maintaining developmental arrest and follicular exclusion of anti-double-stranded DNA B cells.
    Mandik-Nayak L; Seo SJ; Sokol C; Potts KM; Bui A; Erikson J
    J Exp Med; 1999 Jun; 189(11):1799-814. PubMed ID: 10359584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal IgG galactosylation and arthritis in MRL-Fas(lpr) or MRL-FasL(gld) mice are under the control of the MRL genetic background.
    Kuroda Y; Nakata M; Nose M; Kojima N; Mizuochi T
    FEBS Lett; 2001 Oct; 507(2):210-4. PubMed ID: 11684100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional consequences of the developmental arrest and follicular exclusion of anti-double-stranded DNA B cells.
    Mandik-Nayak L; Seo Sj; Eaton-Bassiri A; Allman D; Hardy RR; Erikson J
    J Immunol; 2000 Feb; 164(3):1161-8. PubMed ID: 10640726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of autoantibody production in lpr/lpr mice by transgenic expression of Fas on B cells.
    Shinohara N; Ikegami Y; Yokoyama M; Yonehara S; Komano H
    Ann N Y Acad Sci; 1997 Apr; 815():489-91. PubMed ID: 9186706
    [No Abstract]   [Full Text] [Related]  

  • 7. B cells are required for lupus nephritis in the polygenic, Fas-intact MRL model of systemic autoimmunity.
    Chan OT; Madaio MP; Shlomchik MJ
    J Immunol; 1999 Oct; 163(7):3592-6. PubMed ID: 10490951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Terminal deoxynucleotidyl transferase deficiency decreases autoimmune disease in MRL-Fas(lpr) mice.
    Feeney AJ; Lawson BR; Kono DH; Theofilopoulos AN
    J Immunol; 2001 Sep; 167(6):3486-93. PubMed ID: 11544342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gammadelta T cells promote a Th1 response during coxsackievirus B3 infection in vivo: role of Fas and Fas ligand.
    Huber S; Shi C; Budd RC
    J Virol; 2002 Jul; 76(13):6487-94. PubMed ID: 12050361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spontaneous development of plasmacytoid tumors in mice with defective Fas-Fas ligand interactions.
    Davidson WF; Giese T; Fredrickson TN
    J Exp Med; 1998 Jun; 187(11):1825-38. PubMed ID: 9607923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-Sm B cell differentiation in Ig transgenic MRL/Mp-lpr/lpr mice: altered differentiation and an accelerated response.
    Santulli-Marotto S; Qian Y; Ferguson S; Clarke SH
    J Immunol; 2001 Apr; 166(8):5292-9. PubMed ID: 11290816
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Nagasu A; Mukai T; Iseki M; Kawahara K; Tsuji S; Nagasu H; Ueki Y; Ishihara K; Kashihara N; Morita Y
    Cells; 2019 Apr; 8(5):. PubMed ID: 31052273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-12 deficiency in MRL-Fas(lpr) mice delays nephritis and intrarenal IFN-gamma expression, and diminishes systemic pathology.
    Kikawada E; Lenda DM; Kelley VR
    J Immunol; 2003 Apr; 170(7):3915-25. PubMed ID: 12646661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of effector T cells and Fas ligand on lupus-associated B cells.
    Fields ML; Nish SA; Hondowicz BD; Metzgar MH; Wharton GN; Caton AJ; Erikson J
    J Immunol; 2005 Jul; 175(1):104-11. PubMed ID: 15972636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The origin of anti-nuclear antibodies in bcl-2 transgenic mice.
    Mandik-Nayak L; Nayak S; Sokol C; Eaton-Bassiri A; Madaio MP; Caton AJ; Erikson J
    Int Immunol; 2000 Mar; 12(3):353-64. PubMed ID: 10700470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fas-mediated cytotoxicity is not required for rejection of murine nonvascularized heterotopic cardiac allografts.
    Djamali A; Odorico JS
    Transplantation; 1998 Dec; 66(12):1793-801. PubMed ID: 9884278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Programmed death ligand 1 regulates a critical checkpoint for autoimmune myocarditis and pneumonitis in MRL mice.
    Lucas JA; Menke J; Rabacal WA; Schoen FJ; Sharpe AH; Kelley VR
    J Immunol; 2008 Aug; 181(4):2513-21. PubMed ID: 18684942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Egr-2 in up-regulation of Fas ligand in normal T cells and aberrant double-negative lpr and gld T cells.
    Mittelstadt PR; Ashwell JD
    J Biol Chem; 1999 Jan; 274(5):3222-7. PubMed ID: 9915863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic cells genetically engineered to express Fas ligand induce donor-specific hyporesponsiveness and prolong allograft survival.
    Min WP; Gorczynski R; Huang XY; Kushida M; Kim P; Obataki M; Lei J; Suri RM; Cattral MS
    J Immunol; 2000 Jan; 164(1):161-7. PubMed ID: 10605007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B7 costimulation in the development of lupus: autoimmunity arises either in the absence of B7.1/B7.2 or in the presence of anti-b7.1/B7.2 blocking antibodies.
    Liang B; Gee RJ; Kashgarian MJ; Sharpe AH; Mamula MJ
    J Immunol; 1999 Aug; 163(4):2322-9. PubMed ID: 10438978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.